Charu Aggarwal, MD, MPH, FASCO
@CharuAggarwalMD
Followers
12K
Following
19K
Media
1K
Statuses
8K
Leslye M. Heisler Professor of Lung Cancer Excellence @PennMedicine | AD @PC31 | #CCC Chair @ASCO | Tweets my own | COI: https://t.co/ghKU8KhBvl
Philadelphia, PA
Joined June 2018
So honored to have been interviewed! . Thank you @jamecancerdoc @ASCOPost and looking forward to #ASCO25 @ASCO . @OncoAlert @IMG_Oncologists @HemOncWomenDocs @IASLC .@PennCancer @PennMDForum.
It was my pleasure to talk to @CharuAggarwalMD and learn about her amazing journey from New Delhi to Philadelphia and leadership at @ASCO !! @ASCO @ASCOPost @OncoAlert
4
7
61
RT @StephenVLiu: FLAURA2 press release: addition of chemotherapy to 1L osimertinib in #EGFR NSCLC improves overall survival. Already approv….
astrazeneca.com
0
60
0
RT @StephenVLiu: FDA grants accelerated approval for datopotamab deruxtecan, anti-TROP2 ADC, for #EGFR mutant NSCLC after prior TKI and che….
ascopost.com
The FDA approved the agent for adults with locally advanced or metastatic EGFR-mutated NSCLC who have received prior EGFR-directed therapy and platinum-based chemotherapy.
0
33
0
RT @lungoncdoc: New @US_FDA accelerated approval: Dato-DXd for EGFR+ NSCLC after prior EGFR therapy + platinum chemo. ▫️n=114, TROPIONLung….
0
20
0
RT @OncoAlert: On June 23, 2025, the FDA granted accelerated approval to datopotamab deruxtecan-dlnk for adults with locally advanced or m….
0
17
0
RT @StephenVLiu: FDA approves taletrectinib for #ROS1 NSCLC based on TRUST I and TRUST II trials showing 1L RR 85-90% with 63-72% of respon….
fda.gov
On June 11, 2025, the Food and Drug Administration approved taletrectinib (Ibtrozi, Nuvation Bio Inc.).
0
22
0
RT @StephenVLiu: In this episode of the @IASLC podcast, Lung Cancer Considered, I am joined by Drs. @NarjustFlorezMD @CharuAggarwalMD @Ford….
iaslc.org
This episode of Lung Cancer Considered reviews important lung cancer data presented at ASCO 2025. Lung Cancer Considered hosts Dr. Narjust Florez and Dr. Stephe ...
0
12
0
#RapidUpdates from #ASCO25! This is a must listen quick update in #LungCancer w/ @StephenVLiu @NarjustFlorezMD @FordePatrick @IASLC @ASCO @PennCancer.
Watch for the next episode of the @IASLC podcast, Lung Cancer Considered, for #ASCO25 highlights. Dr. @NarjustFlorezMD and I discuss the most impactful studies from ASCO with Dr. @FordePatrick and Dr. @CharuAggarwalMD. Be sure to listen!
1
7
40
RT @FordePatrick: ~13yrs of neoadjuvant adventure comes to positive conclusion (for now)! In @NEJM today & presented at #ASCO25 5 yr surviv….
0
105
0
RT @BrunaPellini: 🚨If you were not at #ASCO25 for ASCO Highlights today, you must stream @lungoncdoc excellent presentation! Very informati….
0
13
0
RT @BRicciutiMD: Thoughtful discussion in our #ASCO25 session on perioperative approaches in #NSCLC, including rare drivers and hard-to-tre….
0
13
0
RT @DrYukselUrun: Time to Back to the ward. With more knowledge. More energy. More courage. Thank you #ASCO25 for 5 unforgettable days—full….
0
14
0
RT @MarceloCorassa: Great talk by the amazing @CharuAggarwalMD about definition of curative therapy in patients with "common" AGAs, in othe….
0
10
0
RT @OncLive: This is going to be a great session with @CharuAggarwalMD @kaushalpar!! . Biomarker testing absolutely matters even in early-s….
0
4
0
#ASCO25 @ASCO has been incredible - breadth and depth of research presented by @PC3Innovation @PennCancer @PennMedicine @PennMDForum .Here is a quick recap!.#LCSM #QoL #AI #FinancialToxicity.@Ron_cology @lynn_schuchter @MMarmarelis.
pc3i.upenn.edu
PC3I Faculty, Fellows, and staff present 32 Abstracts at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.
0
7
16
RT @lungoncdoc: Last day of #ASCO25!! If you’re still in Chicago this morning, please join us for the highlights of the day session!! . 📍Ha….
0
14
0
🚨 Don’t miss our educational session today!.📍 E450A, 8 AM CT.🎤 @kaushalpar @BRicciutiMD.@ASCO #ASCO25 @OncoAlert #LCSM
#ASCO25 @ASCO Education Book has incredible resources in #LungCancer #LCSM. Super proud of an amazing team of fellows mentored by @kaushalpar @BiagioRicciutMD and me!. @BenBleibergMD @tejavoruganti. So much going on in this space - especially with #NeoADAURA being presented,
0
13
35
RT @crisbergerot: 🔍 Genomics meets the OR in #NSCLC at #ASCO25!.Explore how EGFR, ALK, KRAS, RET & more shape perioperative strategies & su….
0
7
0
🚨 Don’t miss our educational session today!.📍 E450A, 8 AM CT.🎤 @kaushalpar @BRicciutiMD.@ASCO #ASCO25 @OncoAlert #LCSM.
#ASCO25 @ASCO Education Book has incredible resources in #LungCancer #LCSM. Super proud of an amazing team of fellows mentored by @kaushalpar @BiagioRicciutMD and me!. @BenBleibergMD @tejavoruganti. So much going on in this space - especially with #NeoADAURA being presented,
0
7
21
Was so good to see you! Hope to see you soon, congrats on a terrific meeting! @ASCO #ASCO25.@AmandaBinDC @sarah_c_hopkins
Back home. feeling inspired and energized by colleagues, volunteers, friends, members - the whole #ASCO25.community. Only wish I had more time to connect!!.
0
5
11
RT @StephenVLiu: #ASCO25 Dr. @charlesrudin presents interim analysis of DeLLphi-304: randomized phase II study of tarlatamab (DLL3 TCE) vs….
0
39
0